Medicenna Reports First Quarter Fiscal 2022 Financial Results and Operational Highlights

NEXT STORY
POINT Biopharma Reports Second Quarter 2021 Financial Results and Provides Business Update
PREV STORY
Global Advanced Wound Management (AWM) Technology Markets, 2021-2026 – Increasing Acceptance of Innovative Technologies and Protocols for Complex Wound Treatment
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Sentia Medical Sciences Inc. Appoints Dr. Yvette Taché as Chair of the Scientific Advisory Board and Announces Award of a Phase 1 Small Business Innovation Research (SBIR) Grant to Develop Astressins for the Treatment of Irritable Bowel Syndrome (IBS)

SAN DIEGO, June 12, 2018 (GLOBE NEWSWIRE) -- Sentia announced today the appointment of ...

author_avatar
NASDAQ Market News

Portola Pharmaceuticals Announces Topline Results from Phase 3 APEX Trial of Betrixaban for Prevention of Blood Clots in Acute Medically Ill Patients

—Full Data Set to be Presented at International Society of Thrombosis and Haemostasis (ISTH) Congress ...

author_avatar
NASDAQ Market News

Genetic Technologies and The Translational Genomics Research Institute of Phoenix, Arizona Sign Memorandum of Understanding

author_avatar
NASDAQ Market News